—
ATLASense Biomed, a leader in remote health monitoring technology, is set to showcase its revolutionary REPHAEL platform at the Medica Trade Fair, demonstrating groundbreaking advances in continuous health surveillance that extend ICU-grade care beyond hospital walls.
REPHAEL brings critical ICU-level monitoring to a wider range of patients with its PolyMonitor device, a compact, wearable solution that, together with cloud-based analytics, enables proactive health management from virtually anywhere. This powerful combination offers real-time detection and alerts for early signs of cardiac and respiratory distress, fall risks, infections, and sepsis, transforming how critical health issues are managed remotely.
“REPHAEL empowers healthcare providers to deliver ICU-grade insights outside of traditional hospital settings,” said an ATLASense spokesperson. “With our system, clinicians can track vital signs continuously and make informed decisions based on real-time alerts, whether in a clinic, a patient’s home, or remote locations.”
At the core of REPHAEL is its AI-powered capability to deliver proactive health insights, including continuous, cuffless blood pressure monitoring and minute-by-minute updates, enabling early intervention for critical conditions. By predicting potential complications before they escalate, REPHAEL provides healthcare providers with essential tools to intervene early in severe cases such as sepsis, ensuring patients receive timely care.
Designed for adaptability, REPHAEL seamlessly fits into both hospital and home settings, making high-quality monitoring accessible and practical across healthcare frameworks. With Medicare offering full reimbursement for REPHAEL, it is both cost-effective and widely accessible, meeting the growing demand for comprehensive remote monitoring.
“With FDA submission underway, now is an ideal time for investors to consider the transformative potential of the REPHAEL platform,” added the spokesperson. “This technology is poised to redefine proactive patient care and offer stakeholders an opportunity to shape the future of healthcare.”
ATLASense’s dedication to enhancing patient outcomes and reducing healthcare costs is clear in its development of REPHAEL. By presenting this advanced monitoring solution at the Medica Trade Fair, ATLASense continues to set new standards in health technology, aiming for a future where every patient receives top-tier care, regardless of location.
About Us: Guided by a team of Israeli healthcare and MedTech pioneers, ATLASense is committed to developing innovative solutions that empower medical professionals and improve patient outcomes worldwide. The REPHAEL platform, backed by AI and predictive capabilities, is redefining remote monitoring by detecting critical respiratory issues and early sepsis signs, setting a new benchmark in proactive patient care.
Contact Info:
Name: Tal Or
Email: Send Email
Organization: ATLASense Biomed
Address: 1 Ezer Weizman St., Hod Hasharon, Israel, 4502552
Phone: +972-54-770-6688
Website: https://atlasensebiomed.com/
Release ID: 89145893
Google
RSS